Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

298 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson's disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial.
Laurencin C, Timestit N, Marques A, Duchez DD, Giordana C, Meoni S, Huddlestone M, Danaila T, Anheim M, Klinger H, Vidal T, Fatisson M, Caire C, Nourredine M, Boulinguez P, Dhelens C, Ballanger B, Prange S, Bin S, Thobois S. Laurencin C, et al. Among authors: klinger h. J Neurol. 2023 Oct;270(10):4851-4859. doi: 10.1007/s00415-023-11814-y. Epub 2023 Jun 20. J Neurol. 2023. PMID: 37338615 Free PMC article. Clinical Trial.
Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.
Thobois S, Ardouin C, Lhommée E, Klinger H, Lagrange C, Xie J, Fraix V, Coelho Braga MC, Hassani R, Kistner A, Juphard A, Seigneuret E, Chabardes S, Mertens P, Polo G, Reilhac A, Costes N, LeBars D, Savasta M, Tremblay L, Quesada JL, Bosson JL, Benabid AL, Broussolle E, Pollak P, Krack P. Thobois S, et al. Among authors: klinger h. Brain. 2010 Apr;133(Pt 4):1111-27. doi: 10.1093/brain/awq032. Epub 2010 Mar 17. Brain. 2010. PMID: 20237128 Clinical Trial.
[Behavioral disorders in Parkinson's disease: from pathophysiology to the mastery of dopaminergic treatment].
Thobois S, Ardouin C, Schmitt E, Lhommée E, Klinger H, Xie J, Lagrange C, Kistner A, Aya Kombo M, Fleury V, Poisson A, Fraix V, Broussolle E, Pollak P, Krack P. Thobois S, et al. Among authors: klinger h. Rev Neurol (Paris). 2010 Oct;166(10):816-21. doi: 10.1016/j.neurol.2010.07.006. Epub 2010 Aug 23. Rev Neurol (Paris). 2010. PMID: 20739041 Review. French.
Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours.
Lhommée E, Klinger H, Thobois S, Schmitt E, Ardouin C, Bichon A, Kistner A, Fraix V, Xie J, Aya Kombo M, Chabardès S, Seigneuret E, Benabid AL, Mertens P, Polo G, Carnicella S, Quesada JL, Bosson JL, Broussolle E, Pollak P, Krack P. Lhommée E, et al. Among authors: klinger h. Brain. 2012 May;135(Pt 5):1463-77. doi: 10.1093/brain/aws078. Epub 2012 Apr 15. Brain. 2012. PMID: 22508959
Psychostimulant effect of levodopa: reversing sensitisation is possible.
Castrioto A, Kistner A, Klinger H, Lhommée E, Schmitt E, Fraix V, Chabardès S, Mertens P, Quesada JL, Broussolle E, Pollak P, Thobois SC, Krack P. Castrioto A, et al. Among authors: klinger h. J Neurol Neurosurg Psychiatry. 2013 Jan;84(1):18-22. doi: 10.1136/jnnp-2012-302444. Epub 2012 Sep 18. J Neurol Neurosurg Psychiatry. 2013. PMID: 22991345 Clinical Trial.
Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil.
Thobois S, Lhommée E, Klinger H, Ardouin C, Schmitt E, Bichon A, Kistner A, Castrioto A, Xie J, Fraix V, Pelissier P, Chabardes S, Mertens P, Quesada JL, Bosson JL, Pollak P, Broussolle E, Krack P. Thobois S, et al. Among authors: klinger h. Brain. 2013 May;136(Pt 5):1568-77. doi: 10.1093/brain/awt067. Epub 2013 Mar 29. Brain. 2013. PMID: 23543483 Clinical Trial.
298 results